Skip to content
AwardedPRTGoodsFramework agreement€391,186

2023/0491 -OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]

Published
Published 24 June 2026

Overview

OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€391,186
Procedure
Selective
Contract type
Framework agreement
Published
24 June 2026
Classification (CPV)
Pharmaceutical productsAntineoplastic and immunomodulating agents

Award outcome

Awarded value
€391,186
Award date
16 March 2026
Contract period
— → 10 January 2027
Winner
  • NOVARTIS FARMA - PROD.FARM SA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    24 June 2026

Contracting authority

  • Unidade Local de Saúde Santa Maria, E.P.E.

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2023/0491 -OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA] — won by NOVARTIS FARMA - PROD.FARM SA — Skim